Melanoma patients vaccinated with peptides plus adjuvant

Some melanoma patients were vaccinated with the MAGE-A3, gp100, NA17 and tyrosinase peptides presented by HLA-A2 plus the montanide adjuvant, while others were vaccinated with the peptides without the adjuvant or with ALVAC canarypox virus (containing a MAGE-A3 minigene) viral vectors. There was a correlation between tumor regression and detection of anti-MAGE-3.A1 CTL responses.

created over 15 years ago (4 March 2009)    last modified over 13 years ago (28 September 2011)   [ RDF ]   [ RelFinder ]